Arcadia Biosciences Statistics Share Statistics Arcadia Biosciences has 1.37M
shares outstanding. The number of shares has increased by 0.31%
in one year.
Shares Outstanding 1.37M Shares Change (YoY) 0.31% Shares Change (QoQ) 0% Owned by Institutions (%) 5.6% Shares Floating 1.36M Failed to Deliver (FTD) Shares 2,598 FTD / Avg. Volume 23.24%
Short Selling Information The latest short interest is 20.62K, so 1.51% of the outstanding
shares have been sold short.
Short Interest 20.62K Short % of Shares Out 1.51% Short % of Float 1.52% Short Ratio (days to cover) 3.52
Valuation Ratios The PE ratio is -1.15 and the forward
PE ratio is -1.81.
Arcadia Biosciences's PEG ratio is
0.02.
PE Ratio -1.15 Forward PE -1.81 PS Ratio 1.6 Forward PS 0.8 PB Ratio 1.3 P/FCF Ratio -0.84 PEG Ratio 0.02
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Arcadia Biosciences.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 3.61,
with a Debt / Equity ratio of 0.02.
Current Ratio 3.61 Quick Ratio 3.25 Debt / Equity 0.02 Debt / EBITDA -0.02 Debt / FCF -0.02 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $560.56K Profits Per Employee $-782K Employee Count 9 Asset Turnover 0.37 Inventory Turnover 3.28
Taxes Income Tax 8K Effective Tax Rate -0.19%
Stock Price Statistics The stock price has increased by 51.96% in the
last 52 weeks. The beta is 0.51, so Arcadia Biosciences's
price volatility has been higher than the market average.
Beta 0.51 52-Week Price Change 51.96% 50-Day Moving Average 4.52 200-Day Moving Average 4.28 Relative Strength Index (RSI) 46.94 Average Volume (20 Days) 11,177
Income Statement In the last 12 months, Arcadia Biosciences had revenue of 5.04M
and earned -7.04M
in profits. Earnings per share was -5.16.
Revenue 5.04M Gross Profit 2.08M Operating Income -3.65M Net Income -7.04M EBITDA -7.5M EBIT -7.61M Earnings Per Share (EPS) -5.16
Full Income Statement Balance Sheet The company has 4.24M in cash and 155K in
debt, giving a net cash position of 4.09M.
Cash & Cash Equivalents 4.24M Total Debt 155K Net Cash 4.09M Retained Earnings -278.88M Total Assets 7.79M Working Capital 5.74M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -9.63M
and capital expenditures -16K, giving a free cash flow of -9.64M.
Operating Cash Flow -9.63M Capital Expenditures -16K Free Cash Flow -9.64M FCF Per Share -7.07
Full Cash Flow Statement Margins Gross margin is 41.27%, with operating and profit margins of -72.31% and -139.5%.
Gross Margin 41.27% Operating Margin -72.31% Pretax Margin -85.41% Profit Margin -139.5% EBITDA Margin -148.64% EBIT Margin -72.31% FCF Margin -191.14%
Dividends & Yields RKDA does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for RKDA is $6,
which is 40.5% higher than the current price. The consensus rating is "Buy".
Price Target $6 Price Target Difference 40.5% Analyst Consensus Buy Analyst Count 1
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Mar 1, 2023. It was a
backward
split with a ratio of 1:40.
Last Split Date Mar 1, 2023 Split Type backward Split Ratio 1:40
Scores Altman Z-Score -52.54 Piotroski F-Score 1
